Mandate

Vinge advises Apax Partner’s portfolio company Destiny in connection with its acquisition of Soluno

Vinge advises Destiny (a portfolio company of Apax Partners) in connection with its acquisition of the Soluno group (“Soluno”).

Soluno is one of the leading unified communications as a service providers in Europe. The acquisition gives Destiny an instantly strong position in Sweden and also leads to globalisation for Soluno. Following the acquisition, Destiny will comprise of more than 600 employees across 6 countries and is expected to generate a turnover of SEK 1.7 billion in 2021.

Vinge’s team mainly consisted of Christina Kokko, Ulrich Ziche, Hannah Kajlinger and Carl Fredrik Wachtmeister (M&A), Lisa Hörnqvist (Commercial Agreements and GDPR), Mathilda Persson (IT), Ulf Pyk (Real Estate), Josefine Lanker (Banking and Financing), Ebba Svenburg (Employment), Tove Lövgren Frisk (Compliance), Felizia Wiker (IP) and Sara Dahlroos Sköld (VDR specialist).

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026